Singapore, July 9 -- On 9 July 2020, a group of pharmaceutical companies along with Pfizer, Merck (KGaA and the American Merck), Eli Lilly, Novo Nordisk, Boehringer Ingelheim, Bayer Pharmaceuticals and GSK announced a new partnership to bring novel "Pro antibiotics" to the market. With a $1bn fund, the "Antibiotic Innovation Challenge" will acquire or invest in small biotech firms developing antibiotics.

These group of pharmaceutical companies will be assisted by the World Health Organisation and the European Investment Bank. Government officials from Germany, Sweden, France and the UK, as well as representatives from Wellcome Trust and Pew Charitable Trusts joined these companies for announcement.

The global pipeline of novel antibioti...